Evidence map›Paper›PMID 38489541›Full record

ArticleJournal of leukocyte biology2024

TRAF3 regulation of proximal TLR signaling in B cells.

Tiffany K Ybarra, Gail A Bishop

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tiffany K YbarraInterdisciplinary Graduate Program in Immunology, University of Iowa, 285 Newton Road, Iowa City, IA 52242, United States.
Gail A BishopInterdisciplinary Graduate Program in Immunology, University of Iowa, 285 Newton Road, Iowa City, IA 52242, United States.ORCID 0000-0002-1291-5078
University of Iowa · US

Funding

The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI HOUTMAN, JON C.D. · 2002 to 2021
$45.7M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
Regulation of B cell signaling in autoimmunity by TRAF3R01AI162656 · NIAID · UNIVERSITY OF IOWA · PI BISHOP, GAIL A. · 2021 to 2024
$2.0M
Understanding and applying innate and adaptive immune signal interactionsI01BX001702 · VA · IOWA CITY VA MEDICAL CENTER · PI BISHOP, GAIL A. · 2013 to 2020
–
BLRD Research Career Scientist Award ApplicationIK6BX005392 · VA · IOWA CITY VA MEDICAL CENTER · PI GAIL A. BISHOP · 2021 to 2026
–
BLRD VA I01 BX001702BLRD VA IK6 BX005392NCI NIH HHS P50 CA097274NIAID NIH HHS R01 AI162656NIAID NIH HHS T32 AI007485NIEHS NIH HHS P30 ES005605NIH HHS P50 grant CA97274Office of Research and DevelopmentVAVA Senior Research Career Scientist Award 51KBX005392Veterans Health Administration
6 · The paper itself

Abstract

Toll-like receptors are pattern recognition receptors that bridge the innate and adaptive immune responses and are critical for host defense. Most studies of Toll-like receptors have focused upon their roles in myeloid cells. B lymphocytes express most Toll-like receptors and are responsive to Toll-like receptor ligands, yet Toll-like receptor-mediated signaling in B cells is relatively understudied. This is an important knowledge gap, as Toll-like receptor functions can be cell type specific. In striking contrast to myeloid cells, TRAF3 inhibits TLR-mediated functions in B cells. TRAF3-deficient B cells display enhanced IRF3 and NFκB activation, cytokine production, immunoglobulin isotype switching, and antibody production in response to Toll-like receptors 3, 4, 7, and 9. Here, we address the question of how TRAF3 impacts initial B-cell Toll-like receptor signals to regulate downstream activation. We found that TRAF3 in B cells associated with proximal Toll-like receptor 4 and 7 signaling proteins, including MyD88, TRAF6, and the tyrosine kinase Syk. In the absence of TRAF3, TRAF6 showed a greater association with several Toll-like receptor signaling proteins, suggesting that TRAF3 may inhibit TRAF6 access to Toll-like receptor signaling complexes and thus early Toll-like receptor signaling. In addition, our results highlight a key role for Syk in Toll-like receptor signaling in B cells. In the absence of TRAF3, Syk activation was enhanced in response to ligands for Toll-like receptors 4 and 7, and Syk inhibition reduced downstream Toll-like receptor-mediated NFκB activation and proinflammatory cytokine production. This study reveals multiple mechanisms by which TRAF3 serves as a key negative regulator of early Toll-like receptor signaling events in B cells.

Indexed as

B-LymphocytesSignal TransductionTNF Receptor-Associated Factor 3TNF Receptor-Associated Factor 6Toll-Like ReceptorsAnimalsMiceMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88NF-kappa BSyk KinaseMyeloid Differentiation Factor 88NF-kappa BSyk KinaseTNF Receptor-Associated Factor 3TNF Receptor-Associated Factor 6Toll-Like ReceptorsB cellscell signalinginhibition mechanismmyeloid differentiation primary response gene (88) (MyD88)spleen tyrosine kinase (Syk)TNF receptor-associated factor (TRAF)Toll-like receptor (TLR)

Identifiers

PMID38489541
PMCPMC11271984
OpenAlexW4392856594

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.